127 related articles for article (PubMed ID: 20042726)
1. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood.
Prasad RB; Hosking FJ; Vijayakrishnan J; Papaemmanuil E; Koehler R; Greaves M; Sheridan E; Gast A; Kinsey SE; Lightfoot T; Roman E; Taylor M; Pritchard-Jones K; Stanulla M; Schrappe M; Bartram CR; Houlston RS; Kumar R; Hemminki K
Blood; 2010 Mar; 115(9):1765-7. PubMed ID: 20042726
[TBL] [Abstract][Full Text] [Related]
2. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.
Papaemmanuil E; Hosking FJ; Vijayakrishnan J; Price A; Olver B; Sheridan E; Kinsey SE; Lightfoot T; Roman E; Irving JA; Allan JM; Tomlinson IP; Taylor M; Greaves M; Houlston RS
Nat Genet; 2009 Sep; 41(9):1006-10. PubMed ID: 19684604
[TBL] [Abstract][Full Text] [Related]
3. Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population.
Pastorczak A; Górniak P; Sherborne A; Hosking F; Trelińska J; Lejman M; Szczepański T; Borowiec M; Fendler W; Kowalczyk J; Houlston RS; Młynarski W
Leuk Res; 2011 Nov; 35(11):1534-6. PubMed ID: 21889209
[TBL] [Abstract][Full Text] [Related]
4. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.
Xu H; Yang W; Perez-Andreu V; Devidas M; Fan Y; Cheng C; Pei D; Scheet P; Burchard EG; Eng C; Huntsman S; Torgerson DG; Dean M; Winick NJ; Martin PL; Camitta BM; Bowman WP; Willman CL; Carroll WL; Mullighan CG; Bhojwani D; Hunger SP; Pui CH; Evans WE; Relling MV; Loh ML; Yang JJ
J Natl Cancer Inst; 2013 May; 105(10):733-42. PubMed ID: 23512250
[TBL] [Abstract][Full Text] [Related]
5. Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence.
Gharbi H; Ben Hassine I; Soltani I; Safra I; Ouerhani S; Bel Haj Othmen H; Teber M; Farah A; Amouri H; Toumi NH; Abdennebi S; Abbes S; Menif S
Pediatr Hematol Oncol; 2016 Apr; 33(3):157-67. PubMed ID: 27184773
[TBL] [Abstract][Full Text] [Related]
6. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.
Al-Absi B; Razif MFM; Noor SM; Saif-Ali R; Aqlan M; Salem SD; Ahmed RH; Muniandy S
Genet Test Mol Biomarkers; 2017 Oct; 21(10):592-599. PubMed ID: 28768142
[TBL] [Abstract][Full Text] [Related]
7. Association of Genetic Variants in ARID5B, IKZF1 and CEBPE with Risk of Childhood de novo B-Lineage Acute Lymphoblastic Leukemia in India.
Bhandari P; Ahmad F; Mandava S; Das BR
Asian Pac J Cancer Prev; 2016; 17(8):3989-95. PubMed ID: 27644650
[TBL] [Abstract][Full Text] [Related]
8. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population.
Wang Y; Chen J; Li J; Deng J; Rui Y; Lu Q; Wang M; Tong N; Zhang Z; Fang Y
Gene; 2013 Jul; 524(2):203-7. PubMed ID: 23608171
[TBL] [Abstract][Full Text] [Related]
9. Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence.
Vijayakrishnan J; Sherborne AL; Sawangpanich R; Hongeng S; Houlston RS; Pakakasama S
Leuk Lymphoma; 2010 Oct; 51(10):1870-4. PubMed ID: 20919861
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children.
Hsu LI; Chokkalingam AP; Briggs FB; Walsh K; Crouse V; Fu C; Metayer C; Wiemels JL; Barcellos LF; Buffler PA
Cancer Causes Control; 2015 Apr; 26(4):609-19. PubMed ID: 25761407
[TBL] [Abstract][Full Text] [Related]
11. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype.
Migliorini G; Fiege B; Hosking FJ; Ma Y; Kumar R; Sherborne AL; da Silva Filho MI; Vijayakrishnan J; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson P; Hoffmann P; Nöthen MM; Mühleisen TW; Eisele L; Zimmermann M; Bartram CR; Schrappe M; Greaves M; Stanulla M; Hemminki K; Houlston RS
Blood; 2013 Nov; 122(19):3298-307. PubMed ID: 23996088
[TBL] [Abstract][Full Text] [Related]
12. Childhood acute lymphoblastic leukemia-associated risk-loci IKZF1, ARID5B and CEBPE and risk of pediatric non-Hodgkin lymphoma: a report from the Berlin-Frankfurt-Münster Study Group.
Bartram T; Burkhardt B; Wössmann W; Seidemann K; Zimmermann M; Cario G; Lisfeld J; Ellinghaus E; Franke A; Houlston RS; Schrappe M; Reiter A; Stanulla M
Leuk Lymphoma; 2015 Mar; 56(3):814-6. PubMed ID: 25005032
[No Abstract] [Full Text] [Related]
13. High-resolution melting analyses for genetic variants in ARID5B and IKZF1 with childhood acute lymphoblastic leukemia susceptibility loci in Taiwan.
Lin CY; Li MJ; Chang JG; Liu SC; Weng T; Wu KH; Yang SF; Huang FK; Lo WY; Peng CT
Blood Cells Mol Dis; 2014; 52(2-3):140-5. PubMed ID: 24200646
[TBL] [Abstract][Full Text] [Related]
14. Genetic predisposition to B-cell acute lymphoblastic leukemia at 14q11.2 is mediated by a CEBPE promoter polymorphism.
Studd JB; Yang M; Li Z; Vijayakrishnan J; Lu Y; Yeoh AE; Paulsson K; Houlston RS
Leukemia; 2019 Jan; 33(1):1-14. PubMed ID: 29977016
[TBL] [Abstract][Full Text] [Related]
15.
Lopes BA; Barbosa TC; Souza BKS; Poubel CP; Pombo-de-Oliveira MS; Emerenciano M;
Cancer Prev Res (Phila); 2017 Dec; 10(12):738-744. PubMed ID: 28947432
[TBL] [Abstract][Full Text] [Related]
16.
Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study.
Peyrouze P; Guihard S; Grardel N; Berthon C; Pottier N; Pigneux A; Cahn JY; Béné MC; Lhéritier V; Delabesse E; Macintyre E; Thomas X; Dombret H; Ifrah N; Cheok M
Br J Haematol; 2012 Dec; 159(5):599-602. PubMed ID: 23016962
[No Abstract] [Full Text] [Related]
18. Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics.
Chokkalingam AP; Hsu LI; Metayer C; Hansen HM; Month SR; Barcellos LF; Wiemels JL; Buffler PA
Cancer Causes Control; 2013 Oct; 24(10):1789-95. PubMed ID: 23836053
[TBL] [Abstract][Full Text] [Related]
19. Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemia.
Enciso-Mora V; Hosking FJ; Sheridan E; Kinsey SE; Lightfoot T; Roman E; Irving JA; Tomlinson IP; Allan JM; Taylor M; Greaves M; Houlston RS
Leukemia; 2012 Oct; 26(10):2212-5. PubMed ID: 22456626
[TBL] [Abstract][Full Text] [Related]
20. A functional polymorphism in the CEBPE gene promoter influences acute lymphoblastic leukemia risk through interaction with the hematopoietic transcription factor Ikaros.
Wiemels JL; de Smith AJ; Xiao J; Lee ST; Muench MO; Fomin ME; Zhou M; Hansen HM; Termuhlen A; Metayer C; Walsh KM
Leukemia; 2016 May; 30(5):1194-7. PubMed ID: 26437776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
